Robert Burns
Stock Analyst at H.C. Wainwright
(4.90)
# 261
Out of 4,478 analysts
1035
Total ratings
52.1%
Success rate
26.7%
Average return
Main Sectors:
Stocks Rated by Robert Burns
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RVMD Revolution Medicines | Reiterated: Buy | $195 | $189.63 | +2.83% | 46 | Jul 6, 2026 | |
| MOLN Molecular Partners AG | Reiterated: Buy | $13 | $4.04 | +222.18% | 7 | Jul 6, 2026 | |
| EXEL Exelixis | Reiterated: Buy | $56 | $55.05 | +1.73% | 25 | Jul 2, 2026 | |
| FATE Fate Therapeutics | Reiterated: Buy | $7 | $2.88 | +143.06% | 22 | Jun 24, 2026 | |
| ORIC ORIC Pharmaceuticals | Reiterated: Buy | $25 | $11.73 | +113.13% | 48 | Jun 24, 2026 | |
| CGEM Cullinan Therapeutics | Reiterated: Buy | $30 | $17.81 | +68.44% | 10 | Jun 24, 2026 | |
| ZYME Zymeworks | Reiterated: Buy | $46 | $25.45 | +80.75% | 43 | Jun 22, 2026 | |
| ELTX Elicio Therapeutics | Reiterated: Buy | $23 | $3.43 | +571.53% | 15 | Jun 22, 2026 | |
| KPTI Karyopharm Therapeutics | Reiterated: Buy | $13 | $9.57 | +35.84% | 10 | Jun 18, 2026 | |
| COGT Cogent Biosciences | Reiterated: Buy | $55 | $38.50 | +42.86% | 27 | Jun 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $1.82 | +506.06% | 30 | Jun 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $23.51 | +36.14% | 30 | Jun 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $66 | $29.62 | +122.82% | 22 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.18 | - | 45 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $4.35 | +267.82% | 1 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $33 → $35 | $30.29 | +15.57% | 3 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $3.71 | +250.40% | 10 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.29 | - | 13 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $29.33 | +43.20% | 14 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $4.05 | +72.84% | 4 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $28 | $18.91 | +48.07% | 35 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $5.88 | +189.12% | 32 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $1.96 | +461.22% | 41 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $20 | $10.71 | +86.74% | 15 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 | $34.97 | +25.82% | 17 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $56 | $49.93 | +12.16% | 11 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.90 | - | 34 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $8.15 | +255.83% | 7 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $130 | $94.32 | +37.83% | 104 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $8 | $4.97 | +60.97% | 23 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.17 | - | 23 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $11 | $2.10 | +423.81% | 32 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $11.51 | - | 44 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $27 | $9.17 | +194.60% | 4 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $34 → $27 | $4.60 | +486.96% | 7 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $1.59 | +403.14% | 12 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $2.48 | +303.23% | 7 | Feb 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $1.22 | +309.84% | 21 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $11.60 | - | 29 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $19.36 | n/a | 8 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0006 | n/a | 6 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.4601 | n/a | 19 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 → $20 | $0.1429 | n/a | 2 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.2471 | n/a | 13 | Jan 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $35.46 | n/a | 18 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $5.83 | n/a | 7 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $3.82 | n/a | 15 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $1.64 | n/a | 16 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.45 | n/a | 8 | Mar 5, 2021 |
Revolution Medicines
Jul 6, 2026
Reiterated: Buy
Price Target: $195
Current: $189.63
Upside: +2.83%
Molecular Partners AG
Jul 6, 2026
Reiterated: Buy
Price Target: $13
Current: $4.04
Upside: +222.18%
Exelixis
Jul 2, 2026
Reiterated: Buy
Price Target: $56
Current: $55.05
Upside: +1.73%
Fate Therapeutics
Jun 24, 2026
Reiterated: Buy
Price Target: $7
Current: $2.88
Upside: +143.06%
ORIC Pharmaceuticals
Jun 24, 2026
Reiterated: Buy
Price Target: $25
Current: $11.73
Upside: +113.13%
Cullinan Therapeutics
Jun 24, 2026
Reiterated: Buy
Price Target: $30
Current: $17.81
Upside: +68.44%
Zymeworks
Jun 22, 2026
Reiterated: Buy
Price Target: $46
Current: $25.45
Upside: +80.75%
Elicio Therapeutics
Jun 22, 2026
Reiterated: Buy
Price Target: $23
Current: $3.43
Upside: +571.53%
Karyopharm Therapeutics
Jun 18, 2026
Reiterated: Buy
Price Target: $13
Current: $9.57
Upside: +35.84%
Cogent Biosciences
Jun 18, 2026
Reiterated: Buy
Price Target: $55
Current: $38.50
Upside: +42.86%
Jun 16, 2026
Reiterated: Buy
Price Target: $11
Current: $1.82
Upside: +506.06%
Jun 11, 2026
Reiterated: Buy
Price Target: $32
Current: $23.51
Upside: +36.14%
Jun 10, 2026
Reiterated: Buy
Price Target: $27 → $66
Current: $29.62
Upside: +122.82%
Jun 8, 2026
Downgraded: Hold
Price Target: n/a
Current: $1.18
Upside: -
Jun 4, 2026
Initiated Coverage: Buy
Price Target: $16
Current: $4.35
Upside: +267.82%
Jun 3, 2026
Rated: Buy
Price Target: $33 → $35
Current: $30.29
Upside: +15.57%
Jun 1, 2026
Reiterated: Buy
Price Target: $13
Current: $3.71
Upside: +250.40%
Jun 1, 2026
Downgraded: Hold
Price Target: n/a
Current: $1.29
Upside: -
Jun 1, 2026
Reiterated: Buy
Price Target: $42
Current: $29.33
Upside: +43.20%
May 28, 2026
Reiterated: Buy
Price Target: $7
Current: $4.05
Upside: +72.84%
May 26, 2026
Reiterated: Buy
Price Target: $25 → $28
Current: $18.91
Upside: +48.07%
May 26, 2026
Reiterated: Buy
Price Target: $17
Current: $5.88
Upside: +189.12%
May 22, 2026
Reiterated: Buy
Price Target: $11
Current: $1.96
Upside: +461.22%
May 22, 2026
Reiterated: Buy
Price Target: $15 → $20
Current: $10.71
Upside: +86.74%
May 12, 2026
Reiterated: Buy
Price Target: $44
Current: $34.97
Upside: +25.82%
May 11, 2026
Reiterated: Buy
Price Target: $56
Current: $49.93
Upside: +12.16%
May 7, 2026
Reiterated: Hold
Price Target: n/a
Current: $4.90
Upside: -
May 1, 2026
Reiterated: Buy
Price Target: $29
Current: $8.15
Upside: +255.83%
Apr 27, 2026
Reiterated: Buy
Price Target: $130
Current: $94.32
Upside: +37.83%
Apr 27, 2026
Reiterated: Buy
Price Target: $5 → $8
Current: $4.97
Upside: +60.97%
Apr 21, 2026
Reiterated: Hold
Price Target: n/a
Current: $4.17
Upside: -
Apr 16, 2026
Reiterated: Buy
Price Target: $8 → $11
Current: $2.10
Upside: +423.81%
Apr 13, 2026
Downgraded: Sell
Price Target: n/a
Current: $11.51
Upside: -
Mar 23, 2026
Reiterated: Buy
Price Target: $50 → $27
Current: $9.17
Upside: +194.60%
Mar 16, 2026
Maintained: Buy
Price Target: $34 → $27
Current: $4.60
Upside: +486.96%
Feb 13, 2026
Maintained: Buy
Price Target: $8
Current: $1.59
Upside: +403.14%
Feb 3, 2026
Reiterated: Buy
Price Target: $10
Current: $2.48
Upside: +303.23%
Nov 12, 2025
Reiterated: Buy
Price Target: $5
Current: $1.22
Upside: +309.84%
Aug 19, 2025
Reiterated: Hold
Price Target: n/a
Current: $11.60
Upside: -
Sep 3, 2024
Rated: Hold
Price Target: n/a
Current: $19.36
Upside: n/a
Jul 16, 2024
Rated: Hold
Price Target: n/a
Current: $0.0006
Upside: n/a
May 24, 2024
Rated: Hold
Price Target: n/a
Current: $0.4601
Upside: n/a
Mar 21, 2024
Reiterated: Buy
Price Target: $110 → $20
Current: $0.1429
Upside: n/a
Jan 8, 2024
Downgraded: Hold
Price Target: n/a
Current: $0.2471
Upside: n/a
Mar 21, 2023
Reiterated: Hold
Price Target: n/a
Current: $35.46
Upside: n/a
Mar 17, 2023
Reiterated: Buy
Price Target: $22
Current: $5.83
Upside: n/a
May 10, 2022
Reiterated: Buy
Price Target: $11
Current: $3.82
Upside: n/a
Oct 22, 2021
Maintained: Sell
Price Target: n/a
Current: $1.64
Upside: n/a
Mar 5, 2021
Reiterated: Buy
Price Target: $10
Current: $1.45
Upside: n/a